Guggenheim Capital’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-11,285
Closed -$173K – 1942
2023
Q4
$173K Buy
+11,285
New +$158K ﹤0.01% 1814
2022
Q3
– Sell
-10,199
Closed -$183K – 2038
2022
Q2
$183K Buy
10,199
+732
+8% +$17.2K ﹤0.01% 1955
2022
Q1
$274K Buy
+9,467
New +$260K ﹤0.01% 1920
2021
Q3
– Sell
-14,986
Closed -$421K – 2231
2021
Q2
$421K Buy
+14,986
New +$399K ﹤0.01% 1900
2020
Q1
– Sell
-37,288
Closed -$897K – 1999
2019
Q4
$897K Sell
37,288
-1,424
-4% -$32.5K 0.01% 1390
2019
Q3
$817K Buy
38,712
+6,555
+20% +$136K 0.01% 1407
2019
Q2
$709K Sell
32,157
-1,268
-4% -$29.4K 0.01% 1500
2019
Q1
$790K Buy
+33,425
New +$781K 0.01% 1490
2018
Q4
– Sell
-9,744
Closed -$254K – 2361
2018
Q3
$254K Buy
9,744
+2,136
+28% +$59.3K ﹤0.01% 2265
2018
Q2
$205K Sell
7,608
-40,828
-84% -$1.08M ﹤0.01% 2300
2018
Q1
$1.25M Sell
48,436
-8,302
-15% -$227K ﹤0.01% 1951
2017
Q4
$1.56M Sell
56,738
-33,021
-37% -$876K ﹤0.01% 1837
2017
Q3
$2.02M Buy
89,759
+15,943
+22% +$361K ﹤0.01% 1653
2017
Q2
$1.96M Sell
73,816
-23,303
-24% -$622K 0.01% 1641
2017
Q1
$2.65M Sell
97,119
-19,651
-17% -$502K 0.01% 1448
2016
Q4
$2.88M Buy
116,770
+42,623
+57% +$898K 0.01% 1405
2016
Q3
$1.68M Sell
74,147
-9,748
-12% -$213K 0.01% 1732
2016
Q2
$1.59M Sell
83,895
-3,371
-4% -$70.4K 0.01% 1722
2016
Q1
$2.28M Sell
87,266
-20,323
-19% -$470K 0.01% 1474
2015
Q4
$2.77M Buy
107,589
+29,853
+38% +$805K 0.01% 1380
2015
Q3
$1.75M Buy
77,736
+23,569
+44% +$604K 0.01% 1694
2015
Q2
$1.62M Buy
54,167
+1,415
+3% +$39.9K ﹤0.01% 1923
2015
Q1
$1.28M Sell
52,752
-965
-2% -$21.7K ﹤0.01% 2101
2014
Q4
$1.2M Buy
+53,717
New +$1.27M ﹤0.01% 2104
2013
Q4
– Sell
-41,882
Closed -$1.01M – 3255
2013
Q3
$1.01M Buy
41,882
+2,688
+7% +$67.1K ﹤0.01% 2091
2013
Q2
$825K Buy
+39,194
New +$845K ﹤0.01% 2154

Other funds holding TBI

Guggenheim Capital's TBI Position: Q1 2024 in Review

Guggenheim Capital sold out of Trueblue (TBI) in Q1 2024, closing a stake of 11,285 shares — an estimated $173K sold.

Guggenheim Capital first reported a position in TBI in Q2 2013 and held it in 26 quarters. The position peaked at $2.88M in Q4 2016. 137 funds tracked by Wall St. Rank hold TBI as of Q1 2024.

  • Guggenheim Capital reported no remaining Trueblue position as of Q1 2024 after selling out during the quarter.
  • Guggenheim Capital sold 11,285 Trueblue shares in Q1 2024, an estimated $173K.
  • Guggenheim Capital first reported a position in Trueblue in Q2 2013 and held it in 26 quarters.
  • Guggenheim Capital's Trueblue position peaked at $2.88M in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Trueblue as of Q1 2024.

Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.